BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23439027)

  • 21. Serotype-Specific Correlates of Protection for Pneumococcal Carriage: An Analysis of Immunity in 19 Countries.
    Voysey M; Fanshawe TR; Kelly DF; O'Brien KL; Kandasamy R; Shrestha S; Thorson S; Hinds J; Pollard AJ
    Clin Infect Dis; 2018 Mar; 66(6):913-920. PubMed ID: 29069415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.
    Yeh SH; Zangwill KM; Lee H; Chang SJ; Wong VI; Greenberg DP; Ward JI
    Vaccine; 2003 Jun; 21(19-20):2627-31. PubMed ID: 12744899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine.
    Neves FP; Pinto TC; Corrêa MA; dos Anjos Barreto R; de Souza Gouveia Moreira L; Rodrigues HG; Cardoso CA; Barros RR; Teixeira LM
    BMC Infect Dis; 2013 Jul; 13():318. PubMed ID: 23849314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
    Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fundamental link between pneumococcal carriage and disease.
    Simell B; Auranen K; Käyhty H; Goldblatt D; Dagan R; O'Brien KL;
    Expert Rev Vaccines; 2012 Jul; 11(7):841-55. PubMed ID: 22913260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of carriage and transmission of Streptococcus pneumoniae: the beneficial "side effect" of pneumococcal conjugate vaccine.
    Azzari C; Resti M
    Clin Infect Dis; 2008 Oct; 47(8):997-9. PubMed ID: 18781870
    [No Abstract]   [Full Text] [Related]  

  • 30. Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
    Vaccine; 2016 Aug; 34(36):4313-20. PubMed ID: 27422342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.
    Egere U; Townend J; Roca A; Akinsanya A; Bojang A; Nsekpong D; Greenwood B; Adegbola RA; Hill PC
    PLoS One; 2012; 7(11):e49143. PubMed ID: 23185303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
    Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M
    Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower Density and Shorter Duration of Nasopharyngeal Carriage by Pneumococcal Serotype 1 (ST217) May Explain Its Increased Invasiveness over Other Serotypes.
    Bricio-Moreno L; Chaguza C; Yahya R; Shears RK; Cornick JE; Hokamp K; Yang M; Neill DR; French N; Hinton JCD; Everett DB; Kadioglu A
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293378
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era.
    Chen CH; Chen CL; Arguedas A; Southern J; Hsiao CC; Chiu CH
    J Microbiol Immunol Infect; 2020 Dec; 53(6):1035-1038. PubMed ID: 32475800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.
    Wroe PC; Lee GM; Finkelstein JA; Pelton SI; Hanage WP; Lipsitch M; Stevenson AE; Rifas-Shiman SL; Kleinman K; Dutta-Linn MM; Hinrichsen VL; Lakoma M; Huang SS
    Pediatr Infect Dis J; 2012 Mar; 31(3):249-54. PubMed ID: 22173142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.